- Home
- Publications
- Publication Search
- Publication Details
Title
How does TCR-T cell therapy exhibit a superior anti-tumor efficacy
Authors
Keywords
-
Journal
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Volume -, Issue -, Pages 149209
Publisher
Elsevier BV
Online
2023-11-03
DOI
10.1016/j.bbrc.2023.149209
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PI3K–AKT-Targeting Breast Cancer Treatments: Natural Products and Synthetic Compounds
- (2023) Yeqin Yuan et al. Biomolecules
- Targeting the recurrent Rac1P29S neoepitope in melanoma with heterologous high-affinity T cell receptors
- (2023) Lena Immisch et al. Frontiers in Immunology
- One-step CRISPR-Cas9-mediated knockout of native TCRαβ genes in human T cells using RNA electroporation
- (2023) Donovan Flumens et al. STAR Protocols
- Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy
- (2023) Garry Dolton et al. CELL
- Challenges and new technologies in adoptive cell therapy
- (2023) Pengchao Zhang et al. Journal of Hematology & Oncology
- Mismatch repair deficiency is not sufficient to elicit tumor immunogenicity
- (2023) Peter M. K. Westcott et al. NATURE GENETICS
- Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response
- (2022) Jingjing He et al. CELL RESEARCH
- T cell receptors (TCRs) employ diverse strategies to target a p53 cancer neoantigen
- (2022) Daichao Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function
- (2022) Eliana Ruggiero et al. Science Translational Medicine
- Comparing CAR and TCR engineered T cell performance as a function of tumor cell exposure
- (2022) Tassilo L. A. Wachsmann et al. OncoImmunology
- Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer
- (2022) George R Blumenschein et al. Journal for ImmunoTherapy of Cancer
- It’s Getting Complicated—A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy
- (2022) Che-Pei Kung et al. Frontiers in Cell and Developmental Biology
- A tumor metastasis‐associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicity
- (2022) Yuki Yajima et al. CANCER SCIENCE
- Type I interferon-mediated tumor immunity and its role in immunotherapy
- (2022) Renren Yu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Tumor cell-based vaccine: an effective strategy for eradication of cancer cells
- (2022) Seyed Amir Sadeghi Najafabadi et al. Immunotherapy
- Therapeutics Targeting p53-MDM2 Interaction to Induce Cancer Cell Death
- (2022) Nayeong Koo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Engineered cellular immunotherapies in cancer and beyond
- (2022) Amanda V. Finck et al. NATURE MEDICINE
- Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA
- (2022) Smita S. Chandran et al. NATURE MEDICINE
- MDM2 binds and ubiquitinates PARP1 to enhance DNA replication fork progression
- (2022) Celeste Giansanti et al. Cell Reports
- Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects
- (2022) Paul Shafer et al. Frontiers in Immunology
- CXCR4/CXCL12 Activities in the Tumor Microenvironment and Implications for Tumor Immunotherapy
- (2022) Rosanna Mezzapelle et al. Cancers
- Rapid generation of genetically engineered T cells for the treatment of virus‐related cancers
- (2022) Jinxing Jiang et al. CANCER SCIENCE
- Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK ‐rearranged non‐small cell lung cancer
- (2022) Takuya Sakashita et al. CANCER SCIENCE
- NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome
- (2022) Mikiya Ishihara et al. Journal for ImmunoTherapy of Cancer
- Efficacy of pp65‐specific TCR‐T cell therapy in treating cytomegalovirus infection after hematopoietic stem cell transplantation
- (2022) Guangna Liu et al. AMERICAN JOURNAL OF HEMATOLOGY
- CRISPR/Cas9-medaited knockout of endogenous T-cell receptor in Jurkat cells and generation of NY-ESO-1-specific T cells: An in vitro study
- (2022) Pouya Safarzadeh Kozani et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Decitabine enhances targeting of AML cells by NY-ESO-1-specific TCR-T cells and promotes the maintenance of effector function and the memory phenotype
- (2022) Synat Kang et al. ONCOGENE
- Therapeutic high affinity T cell receptor targeting a KRASG12D cancer neoantigen
- (2022) Andrew Poole et al. Nature Communications
- Challenges in neoantigen-directed therapeutics
- (2022) Lien Lybaert et al. CANCER CELL
- Expansion of KRAS hotspot mutations reactive T cells from human pancreatic tumors using autologous T cells as the antigen-presenting cells
- (2022) Sizhen Wang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Time required for commitment to T cell proliferation depends on TCR affinity and cytokine response
- (2022) Liang‐zhe Wu et al. EMBO REPORTS
- p53 as a potential target for treatment of cancer: A perspective on recent advancements in small molecules with structural insights and SAR studies
- (2022) Chahat et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma
- (2022) Valeria Lucarini et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Acetyl-CoA, protein acetylation, and liver cancer
- (2022) Zhengming Wu et al. MOLECULAR CELL
- Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C
- (2022) Rona Yaeger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapid identification of CMV-specific TCRs via reverse TCR cloning system based on bulk TCR repertoire data
- (2022) Cheol-Hwa Hong et al. Frontiers in Immunology
- Tumor-associated antigen Prame targets tumor suppressor p14/ARF for degradation as the receptor protein of CRL2Prame complex
- (2021) Wenjuan Zhang et al. CELL DEATH AND DIFFERENTIATION
- mRNA vaccine for cancer immunotherapy
- (2021) Lei Miao et al. Molecular Cancer
- TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers
- (2021) Nisha B. Nagarsheth et al. NATURE MEDICINE
- Targeting a neoantigen derived from a common TP53 mutation
- (2021) Emily Han-Chung Hsiue et al. SCIENCE
- Avidity optimization of a MAGE‐A1‐specific TCR with somatic hypermutation
- (2021) David Bassan et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Role of Virus-Induced Host Cell Epigenetic Changes in Cancer
- (2021) Valeria Pietropaolo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Histone citrullination: a new target for tumors
- (2021) Dongwei Zhu et al. Molecular Cancer
- Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy
- (2021) Yi Sun et al. Science Translational Medicine
- Targeting cancer testis antigens in synovial sarcoma
- (2021) Geoffrey Mitchell et al. Journal for ImmunoTherapy of Cancer
- NK cells enhance CAR-T cell antitumor efficacy by enhancing immune/tumor cells cluster formation and improving CAR-T cell fitness
- (2021) Mireia Bachiller et al. Journal for ImmunoTherapy of Cancer
- Virus-Driven Carcinogenesis
- (2021) Yuichiro Hatano et al. Cancers
- Evolution of CD8+ T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer
- (2021) Yimo Sun et al. Cells
- Protein Phosphorylation in Cancer: Role of Nitric Oxide Signaling Pathway
- (2021) Xinran Liu et al. Biomolecules
- Tumor associated antigen specific T cells with nivolumab are safe and persist in vivo in rel/ref Hodgkin Lymphoma
- (2021) Hema Dave et al. Blood Advances
- Tumor associated macrophage and microbe: The potential targets of tumor vaccine delivery
- (2021) Jipeng Jiang et al. ADVANCED DRUG DELIVERY REVIEWS
- Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial
- (2021) Fanping Meng et al. Hepatology International
- Human herpesvirus 6 myelitis after chimeric antigen receptor T-cell therapy
- (2021) Guy Handley et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Identification of tumor antigens with immunopeptidomics
- (2021) Chloe Chong et al. NATURE BIOTECHNOLOGY
- Pathogenicity of the MAGE family (Review)
- (2021) Sanyan Li et al. Oncology Letters
- Protein modifications throughout the lung cancer proteome unravel the cancer-specific regulation of glycolysis
- (2021) Yangmiao Duan et al. Cell Reports
- Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
- (2021) Christopher Sloas et al. Frontiers in Immunology
- Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases
- (2021) Xinle Cui et al. Frontiers in Immunology
- Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors
- (2021) Chia-Ing Jan et al. Journal for ImmunoTherapy of Cancer
- Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer
- (2020) Mizuho Ohara et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor Microenvironment
- (2020) Borros Arneth Medicina-Lithuania
- CRISPR-engineered T cells in patients with refractory cancer
- (2020) Edward A. Stadtmauer et al. SCIENCE
- TGFβ2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells
- (2020) Cyril Corbet et al. Nature Communications
- Computational Prediction and Validation of Tumor-Associated Neoantigens
- (2020) Vladimir Roudko et al. Frontiers in Immunology
- Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection
- (2020) Zhongji Meng et al. Frontiers in Immunology
- A Historic Perspective and Overview of H-Ras Structure, Oncogenicity, and Targeting
- (2020) Lihua Shu et al. MOLECULAR CANCER THERAPEUTICS
- High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D
- (2020) Malcolm J. W. Sim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Preclinical Studies of the Off-Target Reactivity of AFP158-Specific TCR Engineered T Cells
- (2020) Lun Cai et al. Frontiers in Immunology
- Selection of a Clinical Lead TCR Targeting Alpha-Fetoprotein-Positive Liver Cancer Based on a Balance of Risk and Benefit
- (2020) Xiaobing Luo et al. Frontiers in Immunology
- Multiple Signaling Roles of CD3ε and Its Application in CAR-T Cell Therapy
- (2020) Wei Wu et al. CELL
- Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma
- (2020) Yifei Zheng et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Targeting p53 for the treatment of cancer
- (2020) Michael J. Duffy et al. SEMINARS IN CANCER BIOLOGY
- Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen
- (2020) Daichao Wu et al. Nature Communications
- KRAS: From undruggable to a druggable Cancer Target
- (2020) Dipesh Uprety et al. CANCER TREATMENT REVIEWS
- HBV as a target for CAR or TCR-T cell therapy
- (2020) Antonio Bertoletti et al. CURRENT OPINION IN IMMUNOLOGY
- Emerging Roles of the MAGE Protein Family in Stress Response Pathways
- (2020) Rebecca R Florke Gee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of Functional HLA-A*01:01–Restricted Epstein-Barr Latent Membrane Protein 2–Specific T-Cell Receptors
- (2020) Wesley Huisman et al. JOURNAL OF INFECTIOUS DISEASES
- The role of ubiquitination and deubiquitination in cancer metabolism
- (2020) Tianshui Sun et al. Molecular Cancer
- Structural dissimilarity from self drives neoepitope escape from immune tolerance
- (2020) Jason R. Devlin et al. Nature Chemical Biology
- Phosphorylation regulates cullin-based ubiquitination in tumorigenesis
- (2020) Yifan Chen et al. Acta Pharmaceutica Sinica B
- Recent developments in immunotherapy of cancers caused by human papillomaviruses
- (2020) Elham Fakhr et al. IMMUNOLOGY
- Tumor microenvironment as a therapeutic target in cancer
- (2020) Yi Xiao et al. PHARMACOLOGY & THERAPEUTICS
- Tumor microenvironment characterization in gastric cancer identifies prognostic and immunotherapeutically relevant gene signatures
- (2019) Dongqiang Zeng et al. Cancer Immunology Research
- Targeting PI3K in cancer: mechanisms and advances in clinical trials
- (2019) Jing Yang et al. Molecular Cancer
- Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers
- (2019) Parisa Malekzadeh et al. JOURNAL OF CLINICAL INVESTIGATION
- The function of RAS mutation in cancer and advances in its drug research
- (2019) Shijie Chen et al. CURRENT PHARMACEUTICAL DESIGN
- Optimizing T‐cell receptor avidity with somatic hypermutation
- (2019) David Bassan et al. INTERNATIONAL JOURNAL OF CANCER
- T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study
- (2019) Stacey L. Doran et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor neoantigens: from basic research to clinical applications
- (2019) Tao Jiang et al. Journal of Hematology & Oncology
- Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer
- (2019) Peter T Harrison et al. SEMINARS IN CANCER BIOLOGY
- Understanding TCR affinity, antigen specificity, and cross-reactivity to improve TCR gene-modified T cells for cancer immunotherapy
- (2019) Timothy T. Spear et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming
- (2019) Alexandre P. Bénéchet et al. NATURE
- Preclinical evaluation of an affinity-enhanced MAGE-A4-specific T-cell receptor for adoptive T-cell therapy
- (2019) Joseph P Sanderson et al. OncoImmunology
- Identification of an HLA‐A*24:02‐restricted α ‐fetoprotein signal peptide‐derived antigen and its specific T‐cell receptor for T‐cell immunotherapy
- (2019) Zhenjuan Li et al. IMMUNOLOGY
- Identification of α-fetoprotein-specific T-cell receptors for hepatocellular carcinoma immunotherapy
- (2018) Wei Zhu et al. HEPATOLOGY
- A humanized TCR retaining authentic specificity and affinity conferred potent anti-tumour cytotoxicity
- (2018) Lin Chen et al. IMMUNOLOGY
- More than just oncogenes: mechanisms of tumorigenesis by human viruses
- (2018) Marta M Gaglia et al. Current Opinion in Virology
- Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM
- (2017) Haitao Ge et al. INTERNATIONAL JOURNAL OF CANCER
- A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens
- (2017) Aaron Y. Chang et al. JOURNAL OF CLINICAL INVESTIGATION
- Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation
- (2017) Ifigeneia Tzannou et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA + Metastatic Colorectal Cancers
- (2017) Chengcheng Zhang et al. MOLECULAR THERAPY
- Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B
- (2017) Paola Fisicaro et al. NATURE MEDICINE
- Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells
- (2017) Waseem Qasim et al. Science Translational Medicine
- Fine-Tuning of Optimal TCR Signaling in Tumor-Redirected CD8 T Cells by Distinct TCR Affinity-Mediated Mechanisms
- (2017) Danilo Presotto et al. Frontiers in Immunology
- HCV T Cell Receptor Chain Modifications to Enhance Expression, Pairing, and Antigen Recognition in T Cells for Adoptive Transfer
- (2017) Kendra C. Foley et al. Molecular Therapy-Oncolytics
- Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma
- (2016) Avery D. Posey et al. IMMUNITY
- IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection
- (2016) Souheil-Antoine Younes et al. JOURNAL OF CLINICAL INVESTIGATION
- Adaptive immunity in HBV infection
- (2016) Antonio Bertoletti et al. JOURNAL OF HEPATOLOGY
- The MAGE protein family and cancer
- (2015) Jenny L Weon et al. CURRENT OPINION IN CELL BIOLOGY
- Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice
- (2015) Matthias Obenaus et al. NATURE BIOTECHNOLOGY
- Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma
- (2015) Longhao Sun et al. TUMOR BIOLOGY
- Signaling in Lymphocyte Activation
- (2015) Doreen Cantrell Cold Spring Harbor Perspectives in Biology
- Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors
- (2015) Q. J. Wang et al. Cancer Immunology Research
- TALEN-mediated editing of endogenous T-cell receptors facilitates efficient reprogramming of T lymphocytes by lentiviral gene transfer
- (2014) B Berdien et al. GENE THERAPY
- Functional Comparison of Engineered T Cells Carrying a Native TCR versus TCR-like Antibody–Based Chimeric Antigen Receptors Indicates Affinity/Avidity Thresholds
- (2014) Ravit Oren et al. JOURNAL OF IMMUNOLOGY
- RNAi-mediated TCR Knockdown Prevents Autoimmunity in Mice Caused by Mixed TCR Dimers Following TCR Gene Transfer
- (2014) Mario Bunse et al. MOLECULAR THERAPY
- Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer
- (2012) Elena Provasi et al. NATURE MEDICINE
- Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety
- (2011) T. Ochi et al. BLOOD
- The molecular basis of the failed immune response in chronic HBV: Therapeutic implications
- (2010) Mala K. Maini et al. JOURNAL OF HEPATOLOGY
- T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
- (2010) Maria R Parkhurst et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search